UpdatesPress Release
Influx Healthtech proposes reallocating ₹10.09 Cr from IPO proceeds.
Influx Healthtech LimitedINFLUX · Filed with the exchange
Funds from veterinary and machinery will now boost its Nutraceutical CDMO Facility (Plot 59) for a significant scale-up (35,000 to 75,000 sq. ft.), enhancing operational capacity and future revenue.
No comments yet. Be the first.